Grade of recommendation | Clarity of risk/benefit | Quality of supporting evidence | Implications |
---|---|---|---|
1A. Strong recommendation, high quality evidence |
Benefits clearly outweigh risk and burdens. | Consistent evidence from well performed randomized, controlled trials or overwhelming evidence of some other form. | Strong recommendation, can apply to most patients in most circumstances without reservation. |
1B. Strong recommendation, moderate quality evidence |
Benefits clearly outweigh risk and burdens. | Evidence from randomized, controlled trials with limitations or very strong evidence of some other research design. | Strong recommendation and applies to most patients. |
1C. Strong recommendation, low quality evidence |
Benefits appear to outweigh risk and burdens. | Evidence from observational studies, unsystematic clinical experience, or case reports. | Strong recommendation, but could change if new evidence appears. |
2A. Weak recommendation, high quality evidence |
Benefits closely balanced with risks and burdens. | Consistent evidence from well performed randomized, controlled trials or overwhelming evidence of some other form. | Weak recommendation, best action may differ depending on circumstances or patients or societal values. |
2B. Weak recommendation, moderate quality evidence |
Benefits closely balanced with risks and burdens. | Evidence from randomized, controlled trials with limitations or very strong evidence of some other research design. | Weak recommendation, alternative approaches likely to be better for some patients under some circumstances. |
2C. Weak recommendation, low quality evidence |
Uncertainty in the estimates of benefits, risks, and burdens; benefits may be closely balanced with risks and burdens. | Evidence from observational studies or case reports. | Very weak recommendation; other alternatives may be equally reasonable. |